Docosatetraenoylethanolamide
Docosatetraenoylethanolamide is an endogenous ethanolamide that has been shown to act on the cannabinoid receptor. DEA is similar in structure to anandamide, containing docosatetraenoic acid in place of arachidonic acid. While DEA has been shown to bind to the CB1 receptor with similar potency and efficacy as AEA, its role as a cannabinergic neurotransmitter is not well understood.
